Pandemic Alliance Munich (PAM)
Your contact
Regina Bach
Project Coordination Pandemic Alliance Munich
More on the topic
-
Tuberculosis remains a global health challenge, claiming over a million lives each year13.04.2026Tuberculosis remains a global health challenge, claiming over a million lives each year -
Ethris receives EU funding of up to EUR 148 million for novel pandemic influenza vaccines through consortium26.02.2026Ethris receives EU funding of up to EUR 148 million for novel pandemic influenza vaccines through consortium -
The registration deadline is 3 April: Biomedical Preparedness and Health Resilience09.02.2026The registration deadline is 3 April: Biomedical Preparedness and Health Resilience
Governance and Organisation
The Pandemic Alliance Munich is a public-private initiative coordinated by BioM. The consortium currently includes leading academic and industrial partners committed to advancing pandemic preparedness.
Collaboration Opportunities
The network and project portfolio are continuously expanding to further strengthen innovation, partnerships, and cross-sector collaboration. For collaboration opportunities or further information, please contact us.
Collaborating to Drive Innovation in Pandemic Preparedness and Health Resilience
The Pandemic Alliance Munich (PAM) is an initiative dedicated to preparing for future pandemic and health threats. It connects stakeholders from research institutions, clinical practice, SMEs, and industry to pool interdisciplinary expertise and accelerate innovation.
The Pandemic Alliance Munich aims to strengthen the scientific, technological, and organizational foundations needed for a rapid and coordinated response to infectious disease outbreaks through close cross-sector collaboration and networking. The focus spans the entire pandemic lifecycle — from prevention, detection, and diagnostics to therapeutic development and clinical as well as structural implementation.
Key Focus Areas:
- Early Detection and Diagnostics
Development and validation of innovative technologies for the early detection and precise diagnosis of pathogens with pandemic potential. - Virus and Immunology Research
Investigation of core viral and immunological mechanisms to predict response patterns in infectious diseases. - Predictive Biomarkers for Therapeutic Strategies
Establishment of predictive biomarkers to enable patient stratification and optimize therapeutic approaches and clinical care strategies. - Collaboration and Knowledge Transfer Structures
Development of cooperative frameworks to ensure effective management of infectious disease events.
“Within the Pandemic Alliance Munich, we are joining forces to improve the diagnosis of pandemic viruses and microbes, as well as our understanding of the pathology they cause. This will help us to be better prepared for a potential new pandemic and to combat biothreats involving the abuse of viruses to threaten our society.“
Collaborative Projects within the PAM consortia
The Pandemic Alliance Munich currently brings together the following joint projects